Castle Biosciences Inc (CSTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 61,493 | 50,138 | 42,037 | 38,338 | 37,011 |
| Cost of Goods | 11,319 | 11,058 | 10,182 | 9,520 | 8,859 |
| Gross Profit | 50,174 | 39,080 | 31,855 | 28,818 | 28,152 |
| Operating Expenses | 60,133 | 60,295 | 63,559 | 52,170 | 50,547 |
| Operating Income | -9,640 | -21,157 | -31,522 | -22,832 | -21,536 |
| Interest Expense | 2 | 3 | 4 | 4 | 6 |
| Other Income | 2,769 | 2,399 | 2,336 | 2,275 | 1,293 |
| Pre-tax Income | -6,873 | -18,761 | -29,190 | -20,561 | -20,249 |
| Income Tax | 32 | 16 | 14 | 57 | N/A |
| Net Income Continuous | -6,905 | -18,777 | -29,204 | -20,618 | -20,249 |
| Net Income | $-6,905 | $-18,777 | $-29,204 | $-20,618 | $-20,249 |
| EPS Basic Total Ops | -0.26 | -0.70 | -1.10 | -0.78 | -0.77 |
| EPS Basic Continuous Ops | -0.26 | -0.70 | -1.10 | -0.78 | -0.77 |
| EPS Diluted Total Ops | -0.26 | -0.70 | -1.10 | -0.78 | -0.77 |
| EPS Diluted Continuous Ops | -0.26 | -0.70 | -1.10 | -0.78 | -0.77 |
| EBITDA(a) | $-8,035 | $-19,170 | $-29,859 | $-21,175 | $-18,797 |